PMC:7600245 / 54786-54996 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T239","span":{"begin":109,"end":117},"obj":"Disease"},{"id":"T240","span":{"begin":152,"end":187},"obj":"Disease"},{"id":"T241","span":{"begin":158,"end":187},"obj":"Disease"}],"attributes":[{"id":"A239","pred":"mondo_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A240","pred":"mondo_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A241","pred":"mondo_id","subj":"T241","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T550","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T63616","span":{"begin":4,"end":8},"obj":"Chemical"}],"attributes":[{"id":"A63175","pred":"chebi_id","subj":"T63616","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T56","span":{"begin":158,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A56","pred":"hp_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T407","span":{"begin":0,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1687","span":{"begin":109,"end":119},"obj":"Species"},{"id":"1688","span":{"begin":123,"end":131},"obj":"Species"},{"id":"1696","span":{"begin":152,"end":187},"obj":"Disease"}],"attributes":[{"id":"A1687","pred":"tao:has_database_id","subj":"1687","obj":"Tax:2697049"},{"id":"A1688","pred":"tao:has_database_id","subj":"1688","obj":"Tax:9606"},{"id":"A1696","pred":"tao:has_database_id","subj":"1696","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The drug is currently being evaluated in a phase 2 randomized, placebo-controlled study for the treatment of SARS-CoV-2 in patients at elevated risk of acute respiratory distress syndrome (NCT04388826; n = 40)."}